Omadacycline for management of Mycobacterium abscessus infections: a review of its effectiveness, place in therapy, and considerations for use
Abstract The Mycobacterium abscessus complex (MABC) is a group of acid-fast, rapidly dividing non-tuberculous mycobacteria (NTM) that include a number of clinically important subspecies, including M. abscessus, M. bolletii, and M. massiliense. These organisms are prevalent in the environment and are...
Main Authors: | Ashley R. Rizzo, Nader H. Moniri |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-022-07857-7 |
Similar Items
-
Omadacycline for the treatment of Mycobacterium abscessus infections: Case series and review of the literature
by: Ayesha Siddiqa, et al.
Published: (2023-01-01) -
Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity In Vitro
by: Anqi Li, et al.
Published: (2023-06-01) -
Scalp Infection Caused by Mycobacterium abscessus Manifested as Patchy Alopecia in an Immunocompetent Female
by: Zhang X, et al.
Published: (2023-08-01) -
Osteomyelitis in the Left First Toe Due to Mycobacterium abscessus after an Injury
by: Yurika Yagi, et al.
Published: (2023-07-01) -
Molecular Epidemiological Characteristics of Mycobacterium abscessus Complex Derived from Non-Cystic Fibrosis Patients in Japan and Taiwan
by: Mitsunori Yoshida, et al.
Published: (2022-06-01)